eHealth (EHTH)
(Delayed Data from NSDQ)
$4.77 USD
+0.05 (1.06%)
Updated May 6, 2024 04:00 PM ET
After-Market: $4.78 +0.01 (0.21%) 6:44 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.77 USD
+0.05 (1.06%)
Updated May 6, 2024 04:00 PM ET
After-Market: $4.78 +0.01 (0.21%) 6:44 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Zacks News
Aon's (AON) Solution to Fetch Higher Value for IP Portfolio
by Zacks Equity Research
Aon (AON) introduces QoIP Solution, which intends to generate higher transaction value for the IP portfolio of companies.
Arthur J. Gallagher (AJG) Buys Optimum Talent, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher (AJG) buys Optimum Talent to enhance senior management relationships across Canada.
EHealth (EHTH) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 33.33% and 9.07%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
eHealth's (EHTH) Q3 results are likely to benefit from solid performance at Medicare and individual and family plan business.
EHealth (EHTH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
EHealth (EHTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
eHealth (EHTH) Gains 55% in a Year: More Room for Upside?
by Zacks Equity Research
Solid performance of the Medicare business positions eHealth (EHTH) for growth.
Arthur J. Gallagher Completes Acquisition of Merriam Agency
by Zacks Equity Research
Arthur J. Gallagher (AJG) buys Merriam Agency to enhance and consolidate its existing capabilities.
Arthur J. Gallagher (AJG) Expands in Southwest With Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Erin P. Collins boosts the acquirer's benefits capabilities across the Southwest apart from providing cross-selling opportunities
Brown & Brown's (BRO) Subsidiary Buys Assets of Brookstone
by Zacks Equity Research
Brown & Brown's (BRO) subsidiary Brown & Brown Lone Star Insurance Services acquires Brookstone to boost its operations in Texas.
Arthur J. Gallagher Buys Kirksey, Strengthens Crop Insurance
by Zacks Equity Research
Arthur J. Gallagher (AJG) buys LA-based Kirksey to strengthen its agricultural capabilities and client offerings.
Brown & Brown Unit's Buyout Consolidates Tennessee Presence
by Zacks Equity Research
Brown & Brown's (BRO) buyout of Frank E. Neal & Co. enhances the acquirer's product portfolio and strengthens its presence in Tennessee.
6 Top-Ranked Stocks That Surged More Than 10% Last Week
by Nalak Das
Several stocks skyrocketed last week and a handful of these were Zacks top-ranked.
Reasons Why Investors Should Retain Willis Towers Stock
by Zacks Equity Research
Willis Towers (WLTW) is poised to benefit from solid customer retention and investment in new business opportunities.
The Zacks Analyst Blog Highlights: SEM, GPK, ATCO, OSB and EHTH
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SEM, GPK, ATCO, OSB and EHTH
Here's Why You Should Keep Aon (AON) Stock in Your Portfolio
by Zacks Equity Research
Riding on inorganic growth measures, Aon (AON) holds prospects of reaping benefits for investors.
5 Long-Term Ideas Still Going Cheap
by Sejuti Banerjea
What could be better than bargain stocks with great long-term potential?
Here's Why Hold Strategy is Apt for Arthur J. Gallagher Stock
by Zacks Equity Research
Arthur J. Gallagher (AJG) continues to benefit from strong segmental performance and numerous M&A activities.
Here's What Makes Brown & Brown (BRO) an Attractive Pick
by Zacks Equity Research
Brown & Brown (BRO) is well poised for growth on the back of strategic mergers and acquisitions, higher commission and fees and higher customer retention.
Here's Why You Should Add eHealth (EHTH) to Your Portfolio
by Zacks Equity Research
Solid performance of the Medicare business makes eHealth (EHTH) well poised for growth.
Why eHealth (EHTH) Stock Might be a Great Pick
by Zacks Equity Research
eHealth (EHTH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks Industry Outlook Highlights: eHealth, Brown & Brown, Arthur J. Gallagher and Marsh & McLennan Companies
by Zacks Equity Research
Zacks Industry Outlook Highlights: eHealth, Brown & Brown, Arthur J. Gallagher and Marsh & McLennan Companies
Bright Near-Term Prospects for Insurance Brokerage Industry
by Tanuka De
Insurance - Brokerage Industry is poised for growth given growing demand for insurance even amid the pandemic.
What's in Store for Arthur J. Gallagher (AJG) in Q2 Earnings?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q2 results are likely to reflect new business production, strategic buyouts, and organic revenue growth.
EHealth (EHTH) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 138.89% and 6.51%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
eHealth's (EHTH) Q2 results are likely to reflect solid performance at Medicare and individual and family plan business.